The Oncology Institute of Hope and Innovation is a clinical research site located in Whittier, California, United States 90603.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
The Oncology Institute of Hope and Innovation has participated in 36 clinical trials with 6 currently active.
Therapeutic areas: Acute Myeloid Leukemia, Cold Agglutinin Disease, Disease Progression.
Sponsors: Sellas Life Sciences Group, Swedish Orphan Biovitrum, Pfizer.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Oncology Institute of Hope and Innovation has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Oncology Institute of Hope and Innovation has 36 clinical trials on record, with 6 currently active. Their work covers Acute Myeloid Leukemia, Cold Agglutinin Disease, Disease Progression.
Yes — The Oncology Institute of Hope and Innovation holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.